文献速递妇科

IL-15超激动剂(ALT-803)增强自然杀伤(NK)细胞抗卵巢癌功能

IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2017-02-22

研究使用IL-15超激动剂复合物ALT-803增强正常供者和卵巢癌患者腹水来源NK细胞的功能,体外实验显示ALT-803增强NK细胞对多种卵巢癌细胞系的细胞毒性和细胞因子产生,并挽救腹水来源NK细胞功能;在MA148-luc卵巢癌NSG异种移植小鼠模型中,仅腹腔注射ALT-803的动物显示NK依赖的肿瘤显著减小。

要点

  • ALT-803增强正常NK细胞对卵巢癌细胞系的CD107a、IFNγ和TNFα表达,增幅因靶细胞系而异。
  • ALT-803可挽救卵巢癌患者腹水来源NK细胞的功能。
  • 仅腹腔注射ALT-803的小鼠显示NK依赖的肿瘤显著减小。

核心结论

  • ALT-803在体外和体内增强NK细胞对卵巢癌的细胞毒性,并能挽救卵巢癌患者腹水来源NK细胞的功能。
  • 这些发现提示ALT-803有潜力增强基于NK细胞的免疫治疗策略用于卵巢癌治疗。

研究设计与样本

  • 体外使用流式细胞术和铬释放试验评估正常供者外周血单个核细胞(PBMC)和卵巢癌患者腹水来源NK细胞在±ALT-803刺激下的功能。
  • 体内使用MA148-luc卵巢癌NOD scid gamma(NSG)异种移植小鼠模型并转移人NK细胞,评估ALT-803增强NK细胞抗卵巢癌功能的能力。

主要发现

  • ALT-803有效增强NK细胞对所有卵巢癌细胞系的功能,CD107a、IFNγ和TNFα表达显著增加,具体取决于靶细胞系。
  • 卵巢癌患者腹水来源NK细胞的功能也被挽救。
  • 仅腹腔注射ALT-803的动物显示NK依赖的肿瘤显著减小。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Natural killer (NK) cells represent a powerful immunotherapeutic target as they lyse tumors directly, do not require differentiation, and can elicit potent inflammatory responses. The objective of these studies was to use an IL-15 super-agonist complex, ALT-803 (Altor BioScience Corporation), to enhance the function of both normal and ovarian cancer patient derived NK cells by increasing cytotoxicity and cytokine production. METHODS: NK cell function from normal donor peripheral blood mononuclear cells (PBMCs) and ovarian cancer patient ascites was assessed using flow cytometry and chromium release assays ±ALT-803 stimulation. To evaluate the ability of ALT-803 to enhance NK cell function in vivo against ovarian cancer, we used a MA148-luc ovarian cancer NOD scid gamma (NSG) xenogeneic mouse model with transferred human NK cells. RESULTS: ALT-803 potently enhanced functionality of NK cells against all ovarian cancer cell lines with significant increases seen in CD107a, IFNγ and TNFα expression depending on target cell line. Function was also rescued in NK cells derived from ovarian cancer patient ascites. Finally, only animals treated with intraperitoneal ALT-803 displayed an NK dependent significant decrease in tumor. CONCLUSIONS: ALT-803 enhances NK cell cytotoxicity against ovarian cancer in vitro and in vivo and is able to rescue functionality of NK cells derived from ovarian cancer patient ascites. These findings suggest that ALT-803 has the potential to enhance NK cell-based immunotherapeutic approaches for the treatment of ovarian cancer.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Felices M, Chu S, Kodal B, et al. IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer. Gynecol Oncol. 2017. PMID: 28236454. doi:10.1016/j.ygyno.2017.02.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。